Li Ziwei (Sharon), a senior associate of Zhong Lun law firm, is mainly engaged in legal affairs in the fields of domestic and overseas listing/refinancing of enterprises, mergers and acquisitions and restructuring of companies, equity financing/venture capital, funds, corporate governance and share incentive. Since 2015, Ms. Li has leaded a number of domestic enterprises to go to A-share, Hong Kong stock and US stock listing/refinancing projects, including but not limited to Changan Automobile (000625), Yixian E-commerce (YSG), Huize Insurance (HUIZ), Kangfeng Bio (06922. HK), China Creative (08368. HK), Tianrui Automobile Internals (06162. HK), Shangjin Holdings (02528. HK), Litian Film (09958. HK), etc. Ms. Li also completed several domestic and overseas equity investment projects on behalf of investment institutions such as Hillhouse Capital, CICC Capital, Hongwei Capital, Zhejin Trust and SDIC Capital. Meanwhile, Ms. Li also served as perennial legal adviser for many domestic and overseas listed companies such as Pumen Technology (688389), Weigao Medical Polymer (01066. HK), Haisike Pharmaceutical (002653), Changan Automobile (000625) and Weili Medical (603309). In 2022, Ms. Li was selected into the New Talent Pool of Foreign Lawyers in Guangdong Province and won the title of "New Talent of Foreign Lawyers in Guangdong Province". Ms. Li is deeply involved in the capital market and pays attention to the growth of start-up enterprises, aiming to provide high-quality legal services for small and medium-sized enterprises in the whole process from start-up to listing, and help create real enterprise value and social value from the perspective of legal industry. Contact details: liziwei@zhonglun.com/18676467550@163.com/ +86 152 1065 9815